Univariate Kaplan-Meier analyses of laboratory biomarkers and clinical parameters showed that CRP, metastatic disease at presentation, and radiotherapy were poor prognostic factors associated with overall survival at 5 years (p < 0.05). This evidence concerns the gene CRP and metastatic neoplasm.